Efficacy and safety of COVID-19 vaccination in patients with cirrhosis

BACKGROUND: The clinical efficacy and safety of vaccination against novel coronavirus disease 2019 (COVID-19) in patients with cirrhosis have not been evaluated yet. AIM: To evaluate the clinical efficacy and safety of vaccination against COVID-19 in patients with cirrhosis. METHODS: This was a retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivashkin, Vladimir, Ismailova, Albina, Dmitrieva, Ksenia, Maslennikov, Roman, Zharkova, Maria, Aliev, Salekh, Bakhitov, Vyacheslav, Marcinkevich, Vadim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376781/
https://www.ncbi.nlm.nih.gov/pubmed/36158923
http://dx.doi.org/10.4254/wjh.v14.i7.1470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376781/
https://www.ncbi.nlm.nih.gov/pubmed/36158923
http://dx.doi.org/10.4254/wjh.v14.i7.1470

Ejemplares similares